Overview
Overview
- Nicole R. Villemarette-Pittman, PhD, is a Director of Clinical Research at Ochsner Health in New Orleans. She joined Ochsner in January 2022 and oversees the Neuroscience Research Center of Excellence, the Cardiology Research Center of Excellence, Ochsner BioDesign Lab, and the Clinical Research Apprenticeship. Dr. Villemarette-Pittman is Co-Chair of the Investigator-Initiated Study Review Committee, Co-Chair of the Research Advisory Council in Neuroscience, Co-lead of the Physician Research Steering Committee Finance Work Group, Member of the Physician Research Steering Committee Communications Work Group, and Member of the Academic Culture Committee. Dr. Villemarette-Pittman is an Associate Professor (Hon) at the University of Queensland Medical School in Brisbane, Australia and Gratis Faculty at LSU Health Sciences Center - New Orleans, Department of Neurology. She is a board member of the LA Epilepsy Foundation. Dr. Villemarette-Pittman and Dr. Fawad Khan are co-founders of the Louisiana Epilepsy Care and Research Consortium. This nonprofit organization seeks to build a society of professionals within the state of Louisiana that focuses on clinical care and research in the epilepsy community. Dr. Villemarette-Pittman serves as Managing Editor of the international neurology journal, Journal of the Neurological Sciences (JNS). JNS is the official journal of the World Federation of Neurology and promotes global neurology, best practices, clinical outcomes, and basic and translational science.
Publications
Selected publications
-
2021Altered mental status predicts length of stay but not death in a community-based cohort of hospitalized COVID-19 patients.. Clinical Neurology and Neurosurgery. 210.
-
2021Application of an evidence-based, out-patient treatment strategy for COVID-19: Multidisciplinary medical practice principles to prevent severe disease*. Journal of the Neurological Sciences. 426.
-
2020Neurological complications in a predominantly African American sample of COVID-19 predict worse outcomes during hospitalization.. Clinical Neurology and Neurosurgery. 197.
-
2020ANXIETY ATTACKS WITH FEATURES SUGGESTING FOCAL SEIZURES SHOULD BE EVALUATED IN THE EPILEPSY MONITORING UNIT. Journal of Investigative Medicine. 68:652-653.
-
2019Dexamethasone as Abortive Treatment for Refractory Seizures or Status Epilepticus in the Inpatient Setting.. Journal of Investigative Medicine High Impact Case Reports. 7.
-
2018EFFECTIVE TREATMENT OF REFRACTORY SEIZURES WITH DEXAMETHASONE IMPLICATES INFLAMMATION IN DRUG-RESISTANT SEIZURES. Journal of Investigative Medicine. 66:585-585.
-
2013Sporadic Creutzfeldt-Jakob disease with focal findings: caveats to current diagnostic criteria.. Neurology International. 5.
-
2013RISK FACTORS FOR THE SEVERITY OF SLEEP APNEA. Journal of Investigative Medicine. 61:493-493.
-
2012Typical Spike-and-Wave Activity in Hypoxic-Ischemic Brain Injury and its Implications for Classifying Nonconvulsive Status Epilepticus.. Clinical Medicine Insights: Case Reports. 5:99-106.
-
2010Predictive utility of type and duration of symptoms at initial presentation in patients with mild cognitive impairment.. Dementia and Geriatric Cognitive Disorders. 30:238-44.
-
2005A comparison of anticonvulsants in the treatment of impulsive aggression.. Experimental and Clinical Psychopharmacology. 13:72-7.
-
2004Obsessive-compulsive personality disorder and behavioral disinhibition.. Journal of Psychology. 138:5-22.
-
2001A double-blind placebo-controlled crossover study of phenytoin in individuals with impulsive aggression.. Psychiatry Research. 103:193-203.
-
2001Physiologic reactivity and impulsive aggression. Psychophysiology. 38:S98-S98.
-
2000Effect of phenytoin on mid-latency evoked potentials in impulsive aggression. Psychophysiology. 37:S49-S49.
Contact
Preferred title
- Director, Clinical Research; Associate Professor (Hon)